GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 113 filers reported holding GW PHARMACEUTICALS PLC in Q3 2015. The put-call ratio across all filers is 2.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $76,370,000 | +326.6% | 352,100 | +127.0% | 0.10% | +400.0% |
| Q4 2020 | $17,900,000 | +113.6% | 155,103 | +80.1% | 0.02% | +137.5% |
| Q3 2020 | $8,382,000 | -68.0% | 86,102 | -65.6% | 0.01% | -60.0% |
| Q4 2019 | $26,158,000 | -24.2% | 250,171 | -16.6% | 0.02% | -31.0% |
| Q3 2019 | $34,509,000 | +1118.1% | 300,000 | +1729.3% | 0.03% | +866.7% |
| Q3 2018 | $2,833,000 | -81.0% | 16,400 | -84.6% | 0.00% | -62.5% |
| Q2 2018 | $14,903,000 | +571.3% | 106,800 | +535.0% | 0.01% | +300.0% |
| Q4 2017 | $2,220,000 | -73.6% | 16,820 | -80.0% | 0.00% | -81.8% |
| Q2 2017 | $8,421,000 | -22.8% | 84,000 | -6.9% | 0.01% | -26.7% |
| Q1 2017 | $10,909,000 | -15.7% | 90,200 | -49.7% | 0.02% | -40.0% |
| Q1 2016 | $12,944,000 | +23.2% | 179,400 | +18.6% | 0.02% | +8.7% |
| Q4 2015 | $10,506,000 | +995.5% | 151,300 | +1341.0% | 0.02% | +1050.0% |
| Q3 2015 | $959,000 | +352.4% | 10,500 | +105.9% | 0.00% | +100.0% |
| Q4 2013 | $212,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |